Healthcare Executive Advisory Board Member – Neuropsychologist

ATCA is recruiting a healthcare executive advisory board member: a distinguished neuropsychologist with a track record in cognitive assessment, dementia evaluation, neurodegenerative disease care, brain-behavior relationships, or scalable clinical program development. This is a board-level engagement for a clinician leader who wants to help shape a differentiated platform addressing one of the most urgent and underserved challenges in modern healthcare: Alzheimer’s disease, dementia, cognitive decline, and related disorders.About Alzheimer’s Treatment Centers of America (ATCA) Alzheimer’s Treatment Centers of America is building the national infrastructure for precision-based Alzheimer’s and dementia care. The model integrates proprietary AI, personalized treatment protocols, and a replicable specialty clinic platform purpose-built to identify the underlying drivers of neurodegeneration and deliver individualized interventions that measurably slow progression. ATCA’s flagship clinic in Palm Beach Gardens/Jupiter is fully operational, payer-integrated, and running at capacity with appointments booked months out. Additional clinics are in active development. The company is executing a disciplined national expansion backed by a multidisciplinary team of healthcare executives, neuroscientists, AI engineers, and clinical specialists.Why Now Proven Demand:The flagship clinic, positioned in a high-visibility corridor adjacent to Cleveland Clinic, reached full capacity rapidly, validating strong market demand for proactive Alzheimer’s and cognitive care. Payer Alignment:Services are reimbursed by Medicare, Medicare Advantage, and major commercial insurers, reducing adoption friction and supporting revenue growth. Demonstrated Outcomes:In a study using ATCA’s AI-driven protocol, 75% of patients with mild cognitive impairment showed no further cognitive decline, creating a meaningful clinical and strategic differentiator. Market Scale:ATCA is positioned within a $355B U.S. Alzheimer’s market and a $1.5T global opportunity, with embedded research infrastructure that can support real-world evidence generation, partnerships, and additional revenue streams. Financial Model:The clinic platform is engineered to target strong EBITDA margins through optimized staffing, a high-acuity service mix, and reimbursement dynamics designed for repeatable multi-market expansion.Key Achievements Proprietary AI Precision Engine:ATCA has built and deployed a defensible AI-driven precision medicine platform that optimizes Alzheimer’s treatment at the individual patient level, creating strong clinical differentiation and long-term data network effects. High-Margin, Replicable Clinic Platform:ATCA has developed a scalable specialty clinic model designed for repeatable expansion, supported by strong unit economics and multi-market rollout potential. Massive, Underserved Market Opportunity:The company is positioned to capture share in one of the largest and fastest-growing unmet-need categories in healthcare. Embedded Revenue and Innovation Infrastructure:Each clinic is designed not only to deliver patient care, but also to generate data, insights, research opportunities, partnerships, and long-term enterprise value.Responsibilities Include As a healthcare executive advisory board member, your contribution centers on four domains: Neuropsychology Leadership:Advise on the evolution and strategic positioning of ATCA’s care model through the lens of neuropsychology, including cognitive evaluation, differential diagnosis, longitudinal assessment, functional interpretation, and the integration of neuropsychological insight into personalized treatment planning. Scalable Clinical Model Development:Guide the standardization and replication of clinic operations across markets, including care pathway design, interdisciplinary structures, and systems that preserve quality while enabling sustainable growth. Cognitive Outcomes, Quality & Care Differentiation:Provide guidance on assessment frameworks, outcome measurement, quality standards, caregiver considerations, and the clinical positioning needed to support a differentiated Alzheimer’s and cognitive care platform. Governance & Responsible Scaling:Advise on AI-enabled care delivery, digital health integration, strategic differentiation, and the governance infrastructure required to scale responsibly and credibly.Why Join Us? Board-Level Leverage:Bring meaningful strategic influence without day-to-day operational demands. Early-Stage Upside:Select roles include equity participation aligned with long-term contribution, with optional access to growth financing initiatives. Meaningful Impact:Help shape a company built to address one of healthcare’s most urgent unmet needs through a model grounded in accountability, innovation, measurable outcomes, and neuropsychology-informed Alzheimer’s care.Compensation / Perks Equity Options:Receive stock options in recognition of your leadership and advisory contributions to ATCA’s mission. Investment Access:Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role.Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.